Alixia (Seed)

Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Funding URL
View Funding Page
Valuation
$18,000,000

Company Info
Founders
Olof Mollstedt
Company Description
Targeting the tumor ecosystems to address cancer drug resistance and improve patients’ lives. Alixia is a medical research company that engages in developing new modalities to treat cancer, aging, and inflammation.
Market
Healthcare & Wellness

Links
Back to Home Back to Healthcare and Biotech Deals View Funding Announcement